These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 1510006)

  • 1. Acute conversion of paroxysmal supraventricular tachycardia with intravenous diltiazem. IV Diltiazem Study Group.
    Dougherty AH; Jackman WM; Naccarelli GV; Friday KJ; Dias VC
    Am J Cardiol; 1992 Sep; 70(6):587-92. PubMed ID: 1510006
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous diltiazem for termination of reentrant supraventricular tachycardia: a placebo-controlled, randomized, double-blind, multicenter study.
    Huycke EC; Sung RJ; Dias VC; Milstein S; Hariman RJ; Platia EV
    J Am Coll Cardiol; 1989 Mar; 13(3):538-44. PubMed ID: 2918157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the electrophysiologic effects of oral sustained-release and intravenous verapamil in patients with paroxysmal supraventricular tachycardia.
    Lai WT; Voon WC; Yen HW; Chang JS; Sheu SH; Hwang YS; Chiu HF
    Am J Cardiol; 1993 Feb; 71(5):405-8. PubMed ID: 8430627
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic effects of intravenous diltiazem in patients with recurrent supraventricular tachycardias.
    Roy D; Marchand E; Chabot M; Gagné P; Waters DD; Bourassa MG
    Can J Cardiol; 1985; 1(5):302-5. PubMed ID: 3842093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
    Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
    Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intravenous diltiazem in patients with paroxysmal re-entrant supraventricular tachycardia.
    Frabetti L; Capucci A; Gerometta PS; Cavallini C; Leto di Priolo S; Magnani B
    Int J Cardiol; 1989 May; 23(2):215-21. PubMed ID: 2722288
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraindividual comparison of diltiazem and verapamil on induction of paroxysmal supraventricular tachycardia.
    Rizos I; Seidl KH; Aidonidis I; Stamou S; Senges J; Toutouzas P
    Cardiology; 1994; 85(6):388-96. PubMed ID: 7697674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Electrophysiologic effect of a new Ca(2+)-antagonist, TA-3090 on supraventricular tachycardia and conduction system].
    Tanno K; Kobayashi Y; Miyata A; Chiyoda K; Nakagawa H; Kurano K; Kikushima S; Yazawa T; Baba T; Mukai H
    Kokyu To Junkan; 1992 Sep; 40(9):897-902. PubMed ID: 1439290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and safety of intravenous sotalol for termination of paroxysmal supraventricular tachycardia. The Sotalol Versus Placebo Multicenter Study Group.
    Jordaens L; Gorgels A; Stroobandt R; Temmerman J
    Am J Cardiol; 1991 Jul; 68(1):35-40. PubMed ID: 2058557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of paroxysmal reentrant supraventricular tachycardia with flecainide acetate.
    Kim SS; Lal R; Ruffy R
    Am J Cardiol; 1986 Jul; 58(1):80-5. PubMed ID: 3728336
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous diltiazem hydrochloride rather than verapamil for resistant paroxysmal supraventricular tachycardia.
    Peitz TJ
    West J Med; 1993 Nov; 159(5):598-9. PubMed ID: 8279162
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias].
    De Rosa F; Feraco E; Venneri N; Boncompagni F; Curia F; Guzzo D; Plastina F
    G Ital Cardiol; 1986 Sep; 16(9):776-81. PubMed ID: 3803800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fast-slow type of atrioventricular nodal reentrant tachycardia: horizontal dissociation of the AV node during tachycardia.
    Fujiki A; Yoshida S; Mizumaki K; Sasayama S
    Pacing Clin Electrophysiol; 1988 Nov; 11(11 Pt 1):1559-65. PubMed ID: 2462240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrophysiologic effects, clinical efficacy and safety of intravenous and oral nadolol in refractory supraventricular tachyarrhythmias.
    Saksena S; Klein GJ; Kowey PR; Calvo RA; Boccadamo R; Brown JE; Sharma AD; Gadhoke A; Olukotun AY
    Am J Cardiol; 1987 Feb; 59(4):307-12. PubMed ID: 3812280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-dependent effects of diltiazem on human atrioventricular nodal properties.
    Talajic M; Lemery R; Roy D; Villemaire C; Cartier R; Coutu B; Nattel S
    Circulation; 1992 Sep; 86(3):870-7. PubMed ID: 1516199
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of diltiazem, verapamil, and inhalation anesthetics on electrophysiologic properties affecting reentrant supraventricular tachycardia in chronically instrumented dogs.
    Atlee JL; Bosnjak ZJ; Yeager TS
    Anesthesiology; 1990 May; 72(5):889-901. PubMed ID: 2339803
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Electrophysiologic and clinical effects of flecainide for recurrent paroxysmal supraventricular tachycardia.
    Hoff PI; Tronstad A; Oie B; Ohm OJ
    Am J Cardiol; 1988 Sep; 62(9):585-9. PubMed ID: 3137798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Self-administered intranasal etripamil using a symptom-prompted, repeat-dose regimen for atrioventricular-nodal-dependent supraventricular tachycardia (RAPID): a multicentre, randomised trial.
    Stambler BS; Camm AJ; Alings M; Dorian P; Heidbuchel H; Houtgraaf J; Kowey PR; Merino JL; Mondésert B; Piccini JP; Pokorney SD; Sager PT; Verma A; Wharton JM; Bharucha DB; Plat F; Shardonofsky S; Chen M; Ip JE;
    Lancet; 2023 Jul; 402(10396):118-128. PubMed ID: 37331368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Electrophysiologic effects of diltiazem hydrochloride on supraventricular tachycardia.
    Rozanski JJ; Zaman L; Castellanos A
    Am J Cardiol; 1982 Feb; 49(3):621-8. PubMed ID: 7058770
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adenosine: electrophysiologic effects and therapeutic use for terminating paroxysmal supraventricular tachycardia.
    DiMarco JP; Sellers TD; Berne RM; West GA; Belardinelli L
    Circulation; 1983 Dec; 68(6):1254-63. PubMed ID: 6640877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.